Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/15384101.2015.1040965

http://scihub22266oqcxt.onion/10.1080/15384101.2015.1040965
suck pdf from google scholar
C4613540!4613540 !25895136
unlimited free pdf from europmc25895136
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid25895136
      Cell+Cycle 2015 ; 14 (12 ): 1859-72
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4 #MMPMID25895136
  • González-Prieto R ; Cuijpers SA ; Kumar R ; Hendriks IA ; Vertegaal AC
  • Cell Cycle 2015[]; 14 (12 ): 1859-72 PMID25895136 show ga
  • c-Myc is the most frequently overexpressed oncogene in tumors, including breast cancer, colon cancer and lung cancer. Post-translational modifications comprising phosphorylation, acetylation and ubiquitylation regulate the activity of c-Myc. Recently, it was shown that c-Myc-driven tumors are strongly dependent on the SUMO pathway. Currently, the relevant SUMO target proteins in this pathway are unknown. Here we show that c-Myc is a target protein for SUMOylation, and that SUMOylated c-Myc is subsequently ubiquitylated and degraded by the proteasome. SUMO chains appeared to be dispensable for this process, polymerization-deficient SUMO mutants supported proteolysis of SUMOylated c-Myc. These results indicate that multiple SUMO monomers conjugated to c-Myc could be sufficient to direct SUMOylated c-Myc to the ubiquitin-proteasome pathway. Knocking down the SUMO-targeted ubiquitin ligase RNF4 enhanced the levels of SUMOylated c-Myc, indicating that RNF4 could recognize a multi-SUMOylated protein as a substrate in addition to poly-SUMOylated proteins. Knocking down the SUMO E3 ligase PIAS1 resulted in reduced c-Myc SUMOylation and increased c-Myc transcriptional activity, indicating that PIAS1 mediates c-Myc SUMOylation. Increased SUMOylation of c-Myc was noted upon knockdown of the SUMO protease SENP7, indicating that it also could regulate a multi-SUMOylated protein in addition to poly-SUMOylated proteins. C-Myc lacks KxE-type SUMOylation consensus motifs. We used mass spectrometry to identify 10 SUMO acceptor lysines: K52, K148, K157, K317, K323, K326, K389, K392, K398 and K430. Intriguingly, mutating all 10 SUMO acceptor lysines did not reduce c-Myc SUMOylation, suggesting that SUMO acceptor lysines in c-Myc act promiscuously. Our results provide novel insight into the complexity of c-Myc post-translational regulation.
  • |*Gene Expression Regulation, Neoplastic [MESH]
  • |Amino Acid Motifs [MESH]
  • |Cell Line, Tumor [MESH]
  • |Cell Nucleus/metabolism [MESH]
  • |Cytoplasm/metabolism [MESH]
  • |Endopeptidases/*metabolism [MESH]
  • |HeLa Cells [MESH]
  • |Humans [MESH]
  • |Lysine/chemistry [MESH]
  • |Mass Spectrometry [MESH]
  • |Nuclear Proteins/*metabolism [MESH]
  • |Phosphorylation [MESH]
  • |Proteasome Endopeptidase Complex/metabolism [MESH]
  • |Protein Inhibitors of Activated STAT/*metabolism [MESH]
  • |Protein Processing, Post-Translational [MESH]
  • |Protein Transport/genetics [MESH]
  • |Proteolysis [MESH]
  • |Proto-Oncogene Proteins c-myc/*metabolism [MESH]
  • |Small Ubiquitin-Related Modifier Proteins/*metabolism [MESH]
  • |Sumoylation [MESH]
  • |Transcription Factors/*metabolism [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box